Insulin glargine and lixisenatide and Tri Femynor
Determining the interaction of Insulin glargine and lixisenatide and Tri Femynor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: ethinyl estradiol / norgestimate
Brand name: Estarylla, Femynor, Mili, Mono-Linyah, Mononessa, Ortho-Cyclen, Tri-Lo-Marzia>
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Tri Vites with Fluoride and Iron
- Insulin glargine and lixisenatide-Tri-Estarylla
- Insulin glargine and lixisenatide-Tri-Legest
- Insulin glargine and lixisenatide-Tri-Legest Fe
- Insulin glargine and lixisenatide-Tri-Linyah
- Insulin glargine and lixisenatide-Tri-Lo-Estarylla
- Tri Femynor-Insulin glargine and lixisenatide Subcutaneous
- Tri Femynor-Insulin glargine, recombinant Subcutaneous
- Tri Femynor-Insulin glulisine
- Tri Femynor-Insulin Glulisine (Cartridges and Pens)
- Tri Femynor-Insulin Glulisine (Vials)
- Tri Femynor-Insulin glulisine Subcutaneous